Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Journal of Biomolecular Screening|June 12, 2004
A miniaturized column chromatography method for measuring receptor-mediated inositol phosphate accumulationElfrida R Benjamin, Sarah L Haftl, Dimitris N Xanthos, et al.Assay and Drug Development Technologies|May 27, 2011
Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disordersKenneth J Valenzano, Richie Khanna, Allan C Powe, et al.Journal of Medicinal Chemistry|February 1, 2013
Pharmacological chaperones as therapeutics for lysosomal storage diseasesRobert E Boyd, Gary Lee, Philip Rybczynski, et al.Journal of Biomolecular Screening|October 20, 2005
State-dependent compound inhibition of Nav1.2 sodium channels using the FLIPR Vm dye: on-target and off-target effects of diverse pharmacological agentsElfrida R Benjamin, Farhana Pruthi, Shakira Olanrewaju, et al.The Journal of Pharmacology and Experimental Therapeutics|September 10, 2010
Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesityPatricia René, Christian Le Gouill, Irina D Pogozheva, et al.Journal of Biomolecular Screening|June 21, 2005
Validation of a fluorescent imaging plate reader membrane potential assay for high-throughput screening of glycine transporter modulatorsElfrida R Benjamin, Joanne Skelton, Denise Hanway, et al.Plos One|July 21, 2012
The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe diseaseRichie Khanna, John J Flanagan, Jessie Feng, et al.Biochemical Pharmacology|July 18, 2006
Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPRElfrida R Benjamin, Farhana Pruthi, Shakira Olanrewaju, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2003
4-(2-pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonistsQun Sun, Laykea Tafesse, Khondaker Islam, et al.Bioorganic & Medicinal Chemistry Letters|September 24, 2004
1,3-Dihydro-2,1,3-benzothiadiazol-2,2-diones and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones as ligands for the NOP receptorR Richard Goehring, John F W Whitehead, K Brown, et al.Pageof 4